PDEX vs UTHR · P/E 16, rev $77.5M vs P/E 20, rev $1.56B
Pro-Dex Inc (PDEX) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Pro-Dex Inc (PDEX) is a medical instruments & supplies company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PDEX revenue for 2026-06-30 was $77.5M. Net income was $13.7M. Revenue was up 16.5% from 2025-06-30 to 2026-06-30. PDEX currently screens at market cap $146.4M and trailing P/E 16.3.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
PDEX currently screens at market cap $146.4M and trailing P/E 16.3. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the PDEX and UTHR stock pages for the full models.
Not investment advice.